Article 1
Active chlorine generated from sodium chloride by electrolysis is approved as an active substance for use in biocidal products of product-type 1 subject to the specifications and conditions set out in the Annex.
Commission Implementing Regulation (EU) 2021/364 of 26 February 2021 approving active chlorine generated from sodium chloride by electrolysis as an active substance for use in biocidal products of product-type 1 (Text with EEA relevance)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
Active chlorine generated from sodium chloride by electrolysis is approved as an active substance for use in biocidal products of product-type 1 subject to the specifications and conditions set out in the Annex.
This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .
ANNEX Common Name IUPAC Name Identification Numbers Minimum degree of purity of the active substance ( 1 ) Date of approval Expiry date of approval Product type Specific conditions Active chlorine generated from sodium chloride by electrolysis IUPAC name: not applicable EC No: not applicable CAS No: not applicable Precursor: IUPAC Name: Sodium Chloride EC No 231-598-3 CAS No 7647-14-5 The specifications for active chlorine generated from sodium chloride by electrolysis in situ are dependent on the precursor sodium chloride which must comply with purity requirements of one of the following standards: NF Brand, EN 973 A, EN 973 B, EN 14805 Type 1, EN 14805 Type 2, EN 16370 Type 1, EN 16370 Type 2, EN 16401 Type 1, EN 16401 Type 2, CODEX STAN 150-1985 or European Pharmacopoeia 9.0. 1 July 2021 30 June 2031 1 The product assessment shall pay particular attention to the exposures, the risks and the efficacy linked to any uses covered by an application for authorisation, but not addressed in the Union-level risk assessment of the active substance. ( 1 ) The purity requirements for the precursor indicated in this column are those provided in the application for the approval of the active substance evaluated.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.